11/12 New updates on our technology blog: wide-field fluorescent imaging on a cell-phone !
09/06 DermaNest publishes its 2013 Industry Survey on Skin and Wound Imaging, with technologiesapplicable for clinicalresearch and distribution.
06/15 MedNest welcomes BCI as a new Client. BCI develops and markets virtual-reality based EDC solutions for clinical research related to brain rehabilitation and cognition.
04/25 MedNest welcomes Intrasense as a new client. Intrasense develops and markets Myrian, a suite of advanced solutions for the review and analysis of Medical Images, also relevant for clinical trials
04/24 Join us and CYTOO at the Harvard Neuro Drug Discovery Center for a Seminar.
03/14 PharmaNest welcomes Dr. Florence Brellier as a new Executive Consultant in Princeton.
02/4 We will be present at the American BioPhysical Society Annual Event (Philadelphia, Feb 2-6). Will be happy to meet there.
01/22 PharmaNest and Accelence announce a series of B2B partnership meetings to enrich Clinical Trials in the area of Neuro-Pharmacology of sleep and vigilance
01/06 Fluigent and PharmaNest sign a Friendship Letter Agreement. Fluigent develops high performance flow controllers for microfluidic applications, with huge potential in particles and single cell handling.
01/5 PharmaNest supports Cytoo at HCA2012 (San Francisco). Come and learn about 2D+
12/30 Happy New Year and Prosperous 2013 !
12/17 PharmaNest supports Cytoo at ASCB 2012 ( San Francisco). Come and learn about 2D+
12/5 PharmaNest congratulates its client CYTOO and Kristine Schauer of Institut Curie for the nomination of 2D+ to the 2013 SLAS innovation Awards (Press Release)
7/28 PharmaNest inks a strategic business development partnership with Accelence (France). Accelence provide Pharmaceutical companies to a certificed Network of Investigators on accelerate patient recruitment and clinical trials quality.
7/10 PharmaNest welcomes Diasys Diagnostics Systems (Germany) as a new client. Diasys is a fast growing company that develops and manufactures a broad range of high quality diagnostic reagents and fully automated clinical chemistry analyzers.
5/15 Cytoo and PharmaNest are pleased to introduce 2D+ : a new dimension in cell culture (PR)
5/15 Meet us today at the Laboratory Robotics Interest Group Meeting, New Brunswick, NJ.
4/17 PharmaNest welcomes Dr. Myles Fennell as a new member of its Industry Advisory Board.
4/17 PharmaNest congratulates Dr. Julie Li for her new position as Leader of the Biology Group at the newly created National center for Advancing Translational Science at the NIH
4/4 Cytoo Announces Venture Partnership with PharmaNest to Launch 2D+ in the USA (Press Release)
4/1 Join the EACCNJ Conference and Workshop
on May23rd, Princeton, NJ and learn how to reach to the FP7 and Horizon 2020 EU Innovation Funds
3/26 PharmaNest continues to develop its partnership with Advantage Austria, Foreign Trade Development Agency of Austria and gives a series of conferences in Linz, Graz and Vienna on the US Healthcare market and opportunities (see more)
2/11 PharmaNest receives its US Trademark Certificate. Welcome TM !
1/20 Come and meet with us at the SLAS Annual Conference, San Diego, Feb 5-7
1/18 PharmaNest is pleased to welcome Dr. Claude Benchimol to its Industry Advisory Board.
1/10 PharmaNest and its venture partner Cytoo participate to HCA (High Content Analysis) meeting in San Francisco
1/9 MedNest and its venture partners are in San Francisco around the JP Morgan conference
01/03 PharmaNest welcomes Cytoo as a new client. Cytoo develops products for cellular analysis and high-content cell screening with reduced cell variability (www.cytoo.com)
12/23 Merry Christmas and Happy New Year
11/18 Kudos to our partner Laurent Erner, CEO of Zenkko, for the launch of a innovative suite of iPad enabled Sensing Technologies. www.masqott.com
11/10 PharmaNest welcomes Accelence as a new client. Accelence is the Clinical Research Network of the greater Bordeaux Area
11/07 PharmaNest welcomes GemacBio as a new client. GemacBio offers a wide range of polyclonal and monoclonal antibodies to non immunogenic small molecules for research and product developpment in multiple TAs.
10/06 Dr. Ralph Garippa (PharmaNest's Industry Advisory Board) announces a webinar on " Trends in Cell-Based Assays and Technologies " .( Join for free here)
10/04 PharmaNest completes its Industry Advisory Board and initiates regular technology / opportunity monthly reviews
9/ 21 PharmaNest gives a conference on "Moving to a US Patient Centric Healthcare" to a panel of entrepreneurs in Vienna, Austria
9/09 PharmaNest participates to the Scientific and Industry Advisory Board of the newly created Clinical Research Network in Bordeaux, France ()
6/28 Private and Public entities partner to create the 1st R&D Accelerator in Healthcare in Europe (Press Release)
6/20 Quick 3D Osteogenic Assay for Stem Cells: congratulations to our client LLTECH and 3DBiotech for their breakthrough imaging of 3D stem Cell Scaffolds. Newsletter.
6/17 Covance's Head of Strategic Market Intelligence Mark Little presents a comprehensive forecast of the CRO markets (MedNest Private Client Conference)
6/16 "High Profile Delegation of LifeSciences CEOs visits America's Medicine Chest State" under the leadership of PharmaNest's Team. Business Wire Press Release.
3/30 PharmaNest supports the launch of the European-American Chamber of Commerce of New Jersey, and sponsors the Life-Science inaugural event with Rutgers Univgersity.
2/30 PharmaNest welcomes Fluofarma as a repeat customer. Fluofarma provides innovative bioengineering, bioscreening and biocomputing services.
2/15 PharmaNest congratulates its client Creapharm for its recent partnership with Bioconvergence. Creapharm provides Fill and Finish services for CytoToxic and High Potency compounds as well as European Clinical Trial Supplies services : see Press Release